{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:45:43Z","timestamp":1790613943815,"version":"4.1.0"},"reference-count":127,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:p>Lewy body dementia is the third most common and costliest type of dementia. It is an umbrella term for dementia with Lewy bodies and Parkinson\u2019s disease dementia, both of which place a substantial burden on the person and society. Recent findings outline ethnoracial differences in dementia risk. Delayed and misdiagnosis across ethnoracial groups contribute to higher levels of burden. In this context, we aimed to summarize current knowledge, gaps, and unmet needs relating to race and ethnicity in Lewy body dementia. In this narrative review, we provide an overview of studies on Lewy body dementia focusing on differences across ethnoracial groups and outline several recommendations for future studies. The majority of the findings comparing different ethnoracial groups were from North American sites. There were no differences in clinical prevalence and progression across ethnoracial groups. Compared to people identifying as non-Hispanic White, co-pathologies were more common and clinical diagnostic accuracy was lower for people identifying as Black. Co-morbidities (e.g., diabetes, hypertension) were more common and medication use rates (e.g., antidepressants, antiparkinsonian agents) were lower for people identifying as Black or Hispanic compared to people identifying as White. More than 90% of clinical trial participants identified as non-Hispanic White. Despite increasing efforts to overcome disparities in Alzheimer\u2019s disease and related dementias, inclusion of individuals from minoritized communities in Lewy body dementia studies continues to be limited and the findings are inconclusive. Representation of diverse populations is crucial to improve the diagnostic and therapeutic efforts in Lewy body dementia.<\/jats:p>","DOI":"10.3233\/jad-230207","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T11:23:06Z","timestamp":1687260186000},"page":"861-878","source":"Crossref","is-referenced-by-count":22,"title":["Race and Ethnicity in Lewy Body Dementia: A Narrative Review"],"prefix":"10.1177","volume":"94","author":[{"given":"Ece","family":"Bayram","sequence":"first","affiliation":[{"name":"Parkinson and Other Movement Disorders Center, Department of Neurosciences, University of California San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Lewy Body Dementia Association Community Engagement Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha K.","family":"Holden","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fullard","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA"},{"name":"Fixel Institute for Neurological Diseases, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230207_ref1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt274","article-title":"The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis","volume":"6","author":"Donaghy","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230207_ref2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: A systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-230207_ref3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson\u2019s disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-230207_ref4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230207_ref5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/gps.2277","article-title":"Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer\u2019s disease with common cognitive tests","volume":"24","author":"Palmqvist","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230207_ref6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-230207_ref8","doi-asserted-by":"crossref","first-page":"805135","DOI":"10.3389\/fneur.2021.805135","article-title":"Fluid and tissue biomarkers of Lewy body dementia: Report of an LBDA symposium","volume":"12","author":"Scott","year":"2022","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-230207_ref9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","article-title":"Epidemiology and economic burden of Lewy body dementia in the United States","volume":"38","author":"Desai","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"10.3233\/JAD-230207_ref10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WAD.0b013e3181c72b5d","article-title":"Lewy body dementia: Caregiver burden and unmet needs","volume":"24","author":"Galvin","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13195-020-00703-5","article-title":"Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials","volume":"12","author":"Goldman","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230207_ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","article-title":"New evidence on the management of Lewy body dementia","volume":"19","author":"Taylor","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-230207_ref13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-802973-2.00009-4","article-title":"Epidemiology of alpha-synucleinopathies: From Parkinson disease to dementia with Lewy bodies","volume":"138","author":"Savica","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.3233\/JAD-230207_ref14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jalz.2019.03.015","article-title":"The costs of dementia subtypes to California Medicare fee-for-service, 2015","volume":"15","author":"Chen","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref15","doi-asserted-by":"crossref","first-page":"e12235","DOI":"10.1002\/dad2.12235","article-title":"Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group","volume":"13","author":"D\u2019Antonio","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-230207_ref16","doi-asserted-by":"crossref","unstructured":"(2021) 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 17, 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"10.3233\/JAD-230207_ref17","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2022.3550","article-title":"Association of race and ethnicity with incidence of dementia among older adults","volume":"327","author":"Kornblith","year":"2022","journal-title":"JAMA"},{"key":"10.3233\/JAD-230207_ref18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-190439","article-title":"Stressful life events and racial disparities in cognition among middle-aged and older adults","volume":"73","author":"Zuelsdorff","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230207_ref19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s41235-021-00329-7","article-title":"Ethnoracial disparities in cognition are associated with multiple socioeconomic status-stress pathways","volume":"6","author":"Letang","year":"2021","journal-title":"Cogn Res Princ Implic"},{"key":"10.3233\/JAD-230207_ref20","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.3390\/ijerph19148865","article-title":"Examine race\/ethnicity disparities in perception, intention, and screening of dementia in a community setting: Scoping review","volume":"19","author":"Lee","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.3233\/JAD-230207_ref21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/14713012211055307","article-title":"Accessibility of health care experienced by persons with dementia from ethnic minority groups and formal and informal caregivers: A scoping review of European literature","volume":"21","author":"Duran-Kira\u00e7","year":"2022","journal-title":"Dementia"},{"key":"10.3233\/JAD-230207_ref22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jamda.2020.06.026","article-title":"Dementia in people from ethnic minority backgrounds: Disability, functioning, and pharmacotherapy at the time of diagnosis","volume":"22","author":"Tsamakis","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.3233\/JAD-230207_ref23","doi-asserted-by":"crossref","first-page":"e2216260","DOI":"10.1001\/jamanetworkopen.2022.16260","article-title":"Racial and ethnic differences in hospice use and hospitalizations at end-of-life among medicare beneficiaries with dementia","volume":"5","author":"Lin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-230207_ref24","doi-asserted-by":"crossref","first-page":"e2233436","DOI":"10.1001\/jamanetworkopen.2022.33436","article-title":"Consumer assessment of healthcare providers and systems among racial and ethnic minority patients with Alzheimer disease and related dementias","volume":"5","author":"Albaroudi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-230207_ref25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/jgs.17345","article-title":"Impact of dementia: Health disparities, population trends, care interventions, and economic costs","volume":"69","author":"Aranda","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-230207_ref26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/WNL.0b013e3182a2cbd1","article-title":"Risk factors for dementia with Lewy bodies: A case-control study","volume":"81","author":"Boot","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref27","doi-asserted-by":"crossref","first-page":"8312346","DOI":"10.1155\/2018\/8312346","article-title":"Metabolic risk factors of Alzheimer\u2019s disease, dementia with Lewy bodies, and normal elderly: A population-based study","volume":"2018","author":"Cheng","year":"2018","journal-title":"Behav Neurol"},{"key":"10.3233\/JAD-230207_ref28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-016-0058-0","article-title":"Meta-analysis of risk factors for Parkinson\u2019s disease dementia","volume":"5","author":"Xu","year":"2016","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JAD-230207_ref29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/13803395.2015.1073227","article-title":"Parkinson\u2019s disease dementia: Diagnostic criteria and risk factor review","volume":"37","author":"Vasconcellos","year":"2015","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-230207_ref30","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1353-8020(13)70026-9","article-title":"Predictors of Parkinson\u2019s disease dementia: Towards targeted therapies for a heterogeneous disease","volume":"20","author":"Moore","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-230207_ref31","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.wnl.0000219812.20616.b3","article-title":"Family history of dementia is a risk factor for Lewy body disease","volume":"66","author":"Woodruff","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0898264308321023","article-title":"Racial disparities in health care access and cardiovascular disease indicators in Black and White older adults in the Health ABC Study","volume":"20","author":"Rooks","year":"2008","journal-title":"J Aging Health"},{"key":"10.3233\/JAD-230207_ref33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WAD.0b013e318211c6c9","article-title":"Diversity and disparity in dementia: The impact of ethnoracial differences in Alzheimer\u2019s disease","volume":"25","author":"Chin","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref34","doi-asserted-by":"crossref","first-page":"e2114364","DOI":"10.1001\/jamanetworkopen.2021.14364","article-title":"Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer disease trial","volume":"4","author":"Raman","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-230207_ref35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.comppsych.2018.12.008","article-title":"Racial\/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: Variation by nativity and socioeconomic status","volume":"89","author":"Vilsaint","year":"2019","journal-title":"Compr Psychiatry"},{"key":"10.3233\/JAD-230207_ref36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/bs11050074","article-title":"Cognitive impairment in Parkinson\u2019s disease: Epidemiology, clinical profile, protective and risk factors","volume":"11","author":"Gonzalez-Latapi","year":"2021","journal-title":"Behav Sci (Basel)"},{"key":"10.3233\/JAD-230207_ref37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.21898","article-title":"The prevalence of Parkinson\u2019s disease in rural Tanzania","volume":"23","author":"Dotchin","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-230207_ref38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JPD-191763","article-title":"Ethnic variation in the manifestation of Parkinson\u2019s disease: A narrative review","volume":"10","author":"Ben-Joseph","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-230207_ref39","first-page":"100136","article-title":"Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study","volume":"7","author":"Llibre-Guerra","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.3233\/JAD-230207_ref40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000254572","article-title":"Different prevalence rates of Parkinson\u2019s disease in urban and rural areas: A population-based study in Taiwan","volume":"33","author":"Chen","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.3233\/JAD-230207_ref41","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999\u20132018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-230207_ref42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13311-022-01193-z","article-title":"Culture, ethnicity, and level of education in Alzheimer\u2019s disease","volume":"19","author":"Rosselli","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-230207_ref43","doi-asserted-by":"crossref","first-page":"115347","DOI":"10.1016\/j.socscimed.2022.115347","article-title":"Eliminating racial disparities in dementia risk by equalizing education quality: A sensitivity analysis","volume":"312","author":"Liu","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.3233\/JAD-230207_ref46","doi-asserted-by":"crossref","first-page":"e0001060","DOI":"10.1371\/journal.pgph.0001060","article-title":"Use of race, ethnicity, and ancestry data in health research","volume":"2","author":"Lu","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.3233\/JAD-230207_ref47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and genetic ancestry in medicine \u2014 a time for reckoning with racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-230207_ref48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2021.0003","article-title":"Recalibrating the use of race in medical research","volume":"325","author":"Ioannidis","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-230207_ref49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-230207_ref50","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2015.2262","article-title":"Race, poverty, and medicine in the United States","volume":"313","author":"Bauchner","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-230207_ref51","doi-asserted-by":"crossref","first-page":"12965","DOI":"10.1038\/s41598-022-16771-6","article-title":"Social determinants and lifestyle factors for brain health: Implications for risk reduction of cognitive decline and dementia","volume":"12","author":"R\u00f6hr","year":"2022","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230207_ref54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A systematic review of prevalence and incidence studies of dementia with Lewy bodies","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-230207_ref55","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with Lewy bodies: A systematic review","volume":"43","author":"Hogan","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-230207_ref56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-230207_ref57","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-230207_ref58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jagp.2018.11.003","article-title":"Dementia prevalence in older adults: Variation by race\/ethnicity and immigrant status","volume":"27","author":"Moon","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230207_ref59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13760-020-01492-2","article-title":"Dementia with Lewy bodies in first-generation immigrants in a European memory clinic","volume":"121","author":"Segers","year":"2020","journal-title":"Acta Neurol Belgica"},{"key":"10.3233\/JAD-230207_ref61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jalz.2016.04.002","article-title":"Prevalence of dementia subtypes in U.S. Medicare fee-for-service beneficiaries, 2011\u20132013","volume":"13","author":"Goodman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.26862","article-title":"Unchanged long-term rural-to-urban incidence ratio of Parkinson\u2019s disease","volume":"32","author":"Isotalo","year":"2017","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-230207_ref63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis","volume":"89","author":"Rizzo","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-230207_ref64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s Uniform Data Set","volume":"32","author":"Besser","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nly049","article-title":"The revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology form\u2014 available data and new analyses","volume":"77","author":"Besser","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-230207_ref66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer\u2019s Coordinating Center (NACC) Database: The uniform data set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JAD-200395","article-title":"Ethnoracial differences in Lewy body diseases with cognitive impairment","volume":"77","author":"Kurasz","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230207_ref68","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3233\/JAD-220297","article-title":"Neuropathological and clinical correlates of Lewy body disease survival by race and ethnicity in the National Alzheimer\u2019s Coordinating Center","volume":"89","author":"Kurasz","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230207_ref69","doi-asserted-by":"crossref","first-page":"e057714","DOI":"10.1002\/alz.057714","article-title":"On gaps of clinical diagnosis of dementia subtypes: A study of Alzheimer\u2019s disease and Lewy body disease","volume":"17","author":"Wei","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: A meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-230207_ref71","doi-asserted-by":"crossref","first-page":"e2140","DOI":"10.1212\/WNL.0000000000200259","article-title":"Clinical trajectories at the end of life in autopsy-confirmed dementia patients With Alzheimer disease and Lewy bodies pathologies","volume":"98","author":"Gu","year":"2022","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref72","doi-asserted-by":"crossref","first-page":"e017504","DOI":"10.1136\/bmjopen-2017-017504","article-title":"Mortality in dementia with Lewy bodies compared with Alzheimer\u2019s dementia: A retrospective naturalistic cohort study","volume":"7","author":"Price","year":"2017","journal-title":"BMJ Open"},{"key":"10.3233\/JAD-230207_ref73","doi-asserted-by":"crossref","first-page":"e0202044","DOI":"10.1371\/journal.pone.0202044","article-title":"Relative survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"13","author":"Larsson","year":"2018","journal-title":"PLoS One"},{"key":"10.3233\/JAD-230207_ref74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.11622\/smedj.2019103","article-title":"Chinese patients with Lewy body dementia had shorter survival and developed complications earlier than those with Alzheimer\u2019s disease","volume":"61","author":"Shea","year":"2020","journal-title":"Singapore Med J"},{"key":"10.3233\/JAD-230207_ref75","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JPD-181367","article-title":"No significant difference in cognitive decline and mortality between Parkinson\u2019s Disease dementia and dementia with Lewy bodies: Naturalistic longitudinal data from the Swedish dementia registry","volume":"8","author":"Fereshtehnejad","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JAD-230207_ref76","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000012450","article-title":"Progression of clinical features in Lewy body dementia can be detected over 6 months","volume":"97","author":"Matar","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneurol.2011.2370","article-title":"Predictors of survival in patients with Parkinson disease","volume":"69","author":"Willis","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-230207_ref78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: A retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-230207_ref79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","article-title":"Age-associated prevalence and risk factors of Lewy body pathology in a general population: The Hisayama study","volume":"106","author":"Wakisaka","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-230207_ref80","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2016.4926","article-title":"Duration and pathologic correlates of Lewy body disease","volume":"74","author":"Graff-Radford","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-230207_ref81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13195-017-0272-8","article-title":"Long-term cognitive outcome of Alzheimer\u2019s disease and dementia with Lewy bodies: Dual disease is worse","volume":"9","author":"Blanc","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230207_ref82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","article-title":"Mixed pathology is more likely in black than white decedents with Alzheimer dementia","volume":"85","author":"Barnes","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and pathological influences of tau pathology in Lewy body disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-230207_ref84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2022.05.024","article-title":"Are there morphological differences between Parkinson\u2019s disease-dementia and dementia with Lewy bodies?","volume":"100","author":"Jellinger","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-230207_ref85","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jalz.2016.03.004","article-title":"Neuropathological differences by race from the National Alzheimer\u2019s Coordinating Center","volume":"12","author":"Graff-Radford","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref86","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1212\/WNL.0000000000012324","article-title":"Association of Lewy bodies with age-related clinical characteristics in Black and White decedents","volume":"97","author":"Nag","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-230207_ref88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/153331750401900309","article-title":"Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians","volume":"19","author":"Mok","year":"2004","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-230207_ref89","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1111\/jan.14932","article-title":"Exploring the experiences of living with Lewy body dementia: An integrative review","volume":"77","author":"Bentley","year":"2021","journal-title":"J Adv Nurs"},{"key":"10.3233\/JAD-230207_ref90","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WAD.0000000000000545","article-title":"Research priorities of individuals and caregivers with Lewy body dementia","volume":"37","author":"Holden","year":"2023","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mdc3.12383","article-title":"The case for antipsychotics in dementia with Lewy bodies","volume":"4","author":"Armstrong","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.3233\/JAD-230207_ref92","first-page":"872","article-title":"Health disparities in dementia","volume":"28","author":"Balls-Berry","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.3233\/JAD-230207_ref93","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JGP.0b013e3181bf9caf","article-title":"A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research","volume":"18","author":"Cooper","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230207_ref94","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WAD.0000000000000174","article-title":"Willingness to be a brain donor","volume":"31","author":"Boise","year":"2017","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-230207_ref95","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40615-020-00839-y","article-title":"Willingness to participate in health research among community-dwelling middle-aged and older adults: Does race\/ethnicity matter?","volume":"8","author":"Milani","year":"2021","journal-title":"J Racial Ethn Heal Disparities"},{"key":"10.3233\/JAD-230207_ref96","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-210231","article-title":"Hispanic perspectives on Parkinson\u2019s disease care and research participation","volume":"81","author":"Damron","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230207_ref97","doi-asserted-by":"crossref","first-page":"e2114606","DOI":"10.1001\/jamanetworkopen.2021.14606","article-title":"Inclusion of underrepresented groups in preclinical Alzheimer disease trials\u2014 opportunities abound","volume":"4","author":"Manly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-230207_ref98","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1037\/neu0000579","article-title":"Group differences in normal neuropsychological test performance for older non-Hispanic White and Black\/African American adults","volume":"33","author":"Werry","year":"2019","journal-title":"Neuropsychology"},{"key":"10.3233\/JAD-230207_ref99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S104161021200213X","article-title":"Cross-cultural differences in dementia: The Sociocultural Health Belief Model","volume":"25","author":"Sayegh","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-230207_ref100","doi-asserted-by":"crossref","first-page":"e200113","DOI":"10.1212\/CPJ.0000000000200113","article-title":"Enrollment of participants from marginalized racial and ethnic groups","volume":"13","author":"Di Luca","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.3233\/JAD-230207_ref101","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.parkreldis.2008.06.005","article-title":"Minority enrollment in Parkinson\u2019s disease clinical trials","volume":"15","author":"Schneider","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-230207_ref102","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-019-0476-1","article-title":"Lewy Body Dementia Association\u2019s Research Centers of Excellence Program: Inaugural meeting proceedings","volume":"11","author":"Peterson","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230207_ref103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jalz.2009.04.1234","article-title":"Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites","volume":"5","author":"Potter","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref104","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1177\/1471301218759836","article-title":"Factors associated with informant-reported cognitive decline in older adults: A systemised literature review","volume":"18","author":"Morrell","year":"2019","journal-title":"Dementia"},{"key":"10.3233\/JAD-230207_ref105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MLR.0000000000001577","article-title":"Dementia diagnosis disparities by race and ethnicity","volume":"59","author":"Lin","year":"2021","journal-title":"Med Care"},{"key":"10.3233\/JAD-230207_ref106","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S1355617719001449","article-title":"Informant reporting in mild cognitive impairment: Sources of discrepancy on the functional activities questionnaire","volume":"26","author":"Hackett","year":"2020","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-230207_ref107","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1377\/hlthaff.2021.00280","article-title":"Family care availability and implications for informal and formal care used by adults with dementia in the US","volume":"40","author":"Choi","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"10.3233\/JAD-230207_ref108","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13854040903058960","article-title":"Increasing culturally competent neuropsychological services for ethnic minority populations: A call to action","volume":"24","author":"Rivera Mindt","year":"2010","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-230207_ref109","first-page":"127","volume-title":"Neuropsychological Assessment of Neuropsychiatric and Neuromedical Disorders","author":"Heaton","year":"2009"},{"key":"10.3233\/JAD-230207_ref110","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/geront\/gnab182","article-title":"Establishing a framework for gathering structural and social determinants of health in Alzheimer\u2019s disease research centers","volume":"62","author":"Stites","year":"2022","journal-title":"Gerontologist"},{"key":"10.3233\/JAD-230207_ref111","doi-asserted-by":"crossref","first-page":"e2235068","DOI":"10.1001\/jamanetworkopen.2022.35068","article-title":"Association of plasma and cerebrospinal fluid Alzheimer disease biomarkers with race and the role of genetic ancestry, vascular comorbidities, and neighborhood factors","volume":"5","author":"Hajjar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-230207_ref112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/alz.12647","article-title":"Medical comorbidities and ethnicity impact plasma Alzheimer\u2019s disease biomarkers: Important considerations for clinical trials and practice","volume":"19","author":"O\u2019Bryant","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref113","doi-asserted-by":"crossref","first-page":"e12315","DOI":"10.1002\/dad2.12315","article-title":"Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI","volume":"14","author":"Windon","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-230207_ref114","first-page":"719","article-title":"Will my soul go to heaven if they take my brain? Beliefs and worries about brain donation among four ethnic groups","volume":"57","author":"Boise","year":"2016","journal-title":"Gerontologist"},{"key":"10.3233\/JAD-230207_ref115","doi-asserted-by":"crossref","first-page":"e0222565","DOI":"10.1371\/journal.pone.0222565","article-title":"African-American and Caucasian participation in postmortem human brain donation for neuropsychiatric research","volume":"14","author":"Deep-Soboslay","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-230207_ref116","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5001\/omj.2015.17","article-title":"Understanding the concept of brain death in the Middle East","volume":"30","author":"Al-Hashim","year":"2015","journal-title":"Oman Med J"},{"key":"10.3233\/JAD-230207_ref117","doi-asserted-by":"crossref","first-page":"e0267705","DOI":"10.1371\/journal.pone.0267705","article-title":"Biological sample donation and informed consent for neurobiobanking: Evidence from a community survey in Ghana and Nigeria","volume":"17","author":"Singh","year":"2022","journal-title":"PLoS One"},{"key":"10.3233\/JAD-230207_ref118","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10561-019-09786-3","article-title":"Why people donate their brain to science: A systematic review","volume":"20","author":"Lin","year":"2019","journal-title":"Cell Tissue Bank"},{"key":"10.3233\/JAD-230207_ref119","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/alz.12433","article-title":"Diversity in Alzheimer\u2019s disease drug trials: The importance of eligibility criteria","volume":"18","author":"Franzen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230207_ref120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrg1229","article-title":"Pharmacogenetics goes genomic","volume":"4","author":"Goldstein","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.3233\/JAD-230207_ref121","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0091270003256065","article-title":"A review and assessment of potential sources of ethnic differences in drug responsiveness","volume":"43","author":"Bjornsson","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.3233\/JAD-230207_ref122","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jamaneurol.2022.2274","article-title":"What should the goals be for diverse recruitment in Alzheimer clinical trials?","volume":"79","author":"Grill","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-230207_ref123","doi-asserted-by":"crossref","first-page":"e12931","DOI":"10.1111\/eci.12931","article-title":"Time to challenge the spurious hierarchy of systematic over narrative reviews?","volume":"48","author":"Greenhalgh","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.3233\/JAD-230207_ref124","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4306\/pi.2015.12.3.417","article-title":"Why systematic review rather than narrative review?","volume":"12","author":"Pae","year":"2015","journal-title":"Psychiatry Investig"},{"key":"10.3233\/JAD-230207_ref125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.23557","article-title":"Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial","volume":"72","author":"Mori","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-230207_ref126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WNF.0000000000000010","article-title":"Long-term safety of rivastigmine in Parkinson disease dementia: An open-label, randomized study","volume":"37","author":"Emre","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JAD-230207_ref127","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sleep.2021.02.038","article-title":"Nelotanserin as symptomatic treatment for rapid eye movement sleep behavior disorder: A double-blind randomized study using video analysis in patients with dementia with Lewy bodies or Parkinson\u2019s disease dementia","volume":"81","author":"Stefani","year":"2021","journal-title":"Sleep Med"},{"key":"10.3233\/JAD-230207_ref128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000351672","article-title":"Long-term safety and efficacy of Donepezil in patients with dementia with Lewy bodies: Results from a 52-week, open-label, multicenter extension study","volume":"36","author":"Ikeda","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-230207_ref129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pcn.12175","article-title":"Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson\u2019s disease with dementia","volume":"68","author":"Tsai","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-230207_ref130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-014-0083-0","article-title":"Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled, confirmatory phase III trial","volume":"7","author":"Ikeda","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-230207_ref131","doi-asserted-by":"crossref","first-page":"e12171","DOI":"10.1002\/trc2.12171","article-title":"An international, randomized, placebo-controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY-DLB)","volume":"7","author":"Lang","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-230207_ref132","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1038\/s41467-022-32944-3","article-title":"Preclinical and randomized clinical evaluation of the p38\u03b1 kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-230207_ref133","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mds.28879","article-title":"Safety and efficacy of mevidalen in Lewy body dementia: A phase 2, randomized, placebo-controlled trial","volume":"37","author":"Biglan","year":"2022","journal-title":"Mov Disord"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:04Z","timestamp":1777370884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230207"}},"subtitle":[],"editor":[{"given":"Lilah","family":"Besser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":127,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-230207","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}